Pharmafile Logo
Pharmafocus logo
Advanced Search

Businesses from the UK are in the top four foreign investors in Flanders in 2022

February 3, 2023
Business Services

Investment figures released this week by Flanders Investment & Trade show that UK businesses are continuing to make significant investments …

News
Press release

IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER

February 3, 2023
Business Services

London, UK, Thursday 2 February 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …

News
Press release

MHRA Approves RINVOQ®▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn’s Disease

February 3, 2023
Business Services

MAIDENHEAD, UK, 01 February 2023 – AbbVie (NYSE: ABBV) today announced that the UK Medicines and Healthcare products Regulatory Agency …

News
Press release

Phlo raises £10m to spearhead digital transformation in pharmacy sector

February 3, 2023
Business Services

[Glasgow, Scotland]  Phlo, UK digital pharmacy leaders, have closed a £10m Series A round led by family office Thairm Bio.   …

News
Press release

Drug-resistant bacteria found in eye drops has infected 55 people in 12 states

February 3, 2023
Medical Communications

A strongly drug-resistant bacteria has been found in multiple brands of artificial tears eyedrops; the most commonly reported was EzriCare …

News

DrugBAN AI expected to reduce costs and speed up drug discovery

February 3, 2023
Medical Communications

In a collaboration between Sheffield University and pharma giant, AstraZeneca, a new AI has been developed which could help deliver …

News

Genoscience Pharma received Orphan Drug Designation for hepatocellular carcinoma drug

February 3, 2023
Medical Communications

French clinical-stage biotech company Genoscience has received FDA Orphan Drug Designation (ODD) for its lead candidate ezurpimtrostat. OOD qualifies the …

News

Insilico Medicine opens new R&D facility in Abu Dhabi

February 3, 2023
Research and Development

Hong Kong-based healthtech company Insilico Medicine recently opened its eighth global laboratory in Abu Dhabi.   Utilising Abu Dhabi’s Masdar …

News

Novartis announces cut to multiple drug research programmes in 2022 full-year report

February 2, 2023
Business Services

Novartis, a Swiss pharmaceutical company, has announced in its 2022 full-year report that it is cutting several of their programmes, …

News
shaking-hands-gb7ac17374_1920

Sherlock Biosciences acquires Sense Biodetection to advance CRISPR-based diagnostics

February 2, 2023
Business Services

US-based biotech company Sherlock Biosciences has acquired UK-based developer of rapid molecular diagnostics Sense Biodetection.   The acquisition will integrate …

News

Tadashi Maruno

February 2, 2023
Sales and Marketing

  Hamamatsu Photonics Announces Mr. Tadashi Maruno as Representative Director and PresidentHamamatsu Photonics, a leading provider of cutting-edge photonics technology, …

Appointment
illumina_joydeep_goswami

Joydeep Goswami

February 2, 2023
Sales and Marketing

Illumina Appoints Joydeep Goswami Chief Financial Officer

Appointment

PureTech to Present at the SVB Securities Global Biopharma Conference

February 1, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …

News
Press release

Ellipses Pharma announces FDA approval of IND application for EP0042 for patients with acute myeloid leukaemia

February 1, 2023
Business Services

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …

News
Press release

ViCentra bolsters leadership team with the appointment of Leo Toole as Chief Financial Officer and expands European commercialization

February 1, 2023
Business Services

February 1, Utrecht, The Netherlands   ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest and most …

News
Press release

Germo Gericke, MD

February 1, 2023
Business Services

Dr. Gericke brings extensive experience in the research and development of radioligand therapies Appointment coincides with launch of Ariceum International …

Appointment

Sequana Medical announces grant of additional DSR® patent in United States

February 1, 2023
Business Services

Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medic

News
Press release

Neuraxpharm announces closing of acquisition of established products from Sanofi

February 1, 2023
Business Services

Düsseldorf and Barcelona – February 1, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …

News
Press release

Dr Jean-Michel Cosséry

February 1, 2023
Business Services

Jean-Michel brings 25 years of experience in the international pharmaceutical and biotech industries both in an executive and non-executive capacity …

Appointment

COVID-19 treatments drive Pfizer’s annual earnings up to $100bn

February 1, 2023
Sales and Marketing

Big Pharma giant Pfizer’s annual earnings in 2022 reached $100bn, a considerable proportion of which came from its COVID-19 vaccine …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026